SunTrust Robinson Humphrey Initiates Coverage On Amgen with Buy Rating, Announces $256 Price Target

SunTrust Robinson Humphrey initiates coverage on Amgen (NASDAQ:AMGN) with a Buy rating and a $256 price target.

Benzinga · 11/12/2019 11:05

SunTrust Robinson Humphrey initiates coverage on Amgen (NASDAQ:AMGN) with a Buy rating and a $256 price target.